总统变更通知
Notice of Change in President
阅读中文说明与多语对照DAIWA NEWS & EVENTS
中文为主要阅读文字,英文官方内容作弱显示对照;内容与日本大和官网同步发布翻译。
Notice of Change in President
阅读中文说明与多语对照DHD USA exhibited at Natural Products Expo West 2025
阅读中文说明与多语对照Newly Registered Rice Kefiran Patent
阅读中文说明与多语对照New Research Publication: Rice Kefiran Ameliorates Obesity and Hepatic Steatosis Through Changes in Gut Microbiota
阅读中文说明与多语对照Daiwa Held “Daiwa International Workshop 2024” in Kyoto
阅读中文说明与多语对照Daiwa exhibited at “Vitafoods Asia 2024 (Thailand)”
阅读中文说明与多语对照Newly published research paper: Improvement in Epigenetic Aging Clock Induced by BioBran Containing Rice Kefiran in Relation to Various Biomarkers: A Pilot Study
阅读中文说明与多语对照Newly published research paper: Rice bran arabinoxylan compound as a natural product for cancer treatment – an evidence-based assessment of the effects and mechanisms
阅读中文说明与多语对照Indonesian Physicians Visit Japan to Attend Daiwa Pharmaceutical Seminar
阅读中文说明与多语对照New published research paper: BioBran/MGN-3, an Arabinoxylan Rice Bran, Exerts Anti-COVID-19 Effects and Boosts Immunity in Human Subjects
阅读中文说明与多语对照Academic presentation: The 7th International Multidisciplinary Breast Conference (UAE)
阅读中文说明与多语对照Book on BioBran Published
阅读中文说明与多语对照New published research paper: Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study
阅读中文说明与多语对照Exhibition: Pet Fair South East Asia 2023
阅读中文说明与多语对照New published research paper: Modified Rice Bran Arabinoxylan by Lentinus edodes Mycelial Enzyme as an Immunoceutical for Health and Aging-A Comprehensive Literature Review”
阅读中文说明与多语对照New published research paper: Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis
阅读中文说明与多语对照New published research paper:” Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound”
阅读中文说明与多语对照New published research paper: “Effects of Dietary Bacillus natto Productive Protein on the Skin: In Vitro Efficacy Test and Single-Armed Trial”
阅读中文说明与多语对照Exhibition: Vitafoods Asia 2023
阅读中文说明与多语对照Webinar for Daiwa’s business partners
阅读中文说明与多语对照来源:大和药品株式会社日本官网;本站同步核对日期:2026-09-01;版权授权有效期至2030年5月31日。